Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Probiotics may help treat skin conditions like acne and eczema safely.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Tofacitinib is an effective and safe treatment for alopecia areata.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Oral alitretinoin can quickly regrow hair in alopecia universalis.

Ritlecitinib is an effective new treatment for Alopecia Areata.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Vitamin D may help reduce thyroid antibodies and improve thyroid function in Hashimoto's Thyroiditis.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Vitamin A affects hair loss and immune response in alopecia areata.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Alopecia areata patients have higher levels of IL-6 and TNF-α.